Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of the Natural Progression of Interstitial Lung Disease

NCT04896138 is registered in ClinicalTrials.gov with University of Virginia as lead sponsor.

NCT NCT04896138
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04896138 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of the Natural Progression of Interstitial Lung Disease
Lead sponsor
University of Virginia
Phase
Observational
Overall status
Enrolling by invitation
Start date
August 28, 2018
Completion date
August 31, 2035
Enrollment
2,500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

connective tissue diseases, hypersensitivity pneumonitis, idiopathic interstitial pneumonias, idiopathic pulmonary fibrosis, interstitial lung disease, sarcoidosis